Skip to main content

Table 1 Relative risks of tobacco related disease in Swedish males

From: Using data on snus use in Sweden to compare different modelling approaches to estimate the population health impact of introducing a smoke-free tobacco product

  Age range Relative Risk (95% CI) Current smoker Relative Risk (95% CI) Former smoker Relative Risk (95% CI) Current snus
Lung Cancer Any 8.68 (7.14–10.54) 2.62 (2.01–3.42) 0.80 (0.60–1.06)
COPD Any 3.31 (2.80–3.92) 1.99 (1.76–2.25) 0.80 (0.40–1.60)
IHD to 54
55 to 64
65 to 74
75 to 79
Any
3.38 (2.92–3.91)
2.32 (2.05–2.62)
1.70 (1.56–1.86)
1.27 (1.21–1.33)
1.36 (1.21–1.53)
1.38 (1.22–1.55)
1.25 (1.16–1.34)
1.16 (1.08–1.25)
1.01 (0.91–1.12)
Stroke to 54
55 to 64
65 to 74
75 to 79
Any
2.48 (1.94–3.17)
2.13 (1.93–2.34)
1.39 (1.23–1.58)
1.06 (0.96–1.17)
1.10 (0.90–1.34)
1.17 (1.01–1.36)
1.15 (1.04–1.26)
1.00 (0.89–1.12)
1.04 (0.92–1.17)
  1. Table 1 presents relative risks for lung cancer, COPD, IHD and stroke for current and former smokers compared to never smokers and for current snus users relative to never users. Estimates for IHD and stroke for smoking are given by age, but other relative risks are assumed to be independent of age. The estimates for smoking come from published meta-analyses for lung cancer [15], for COPD [16], and for IHD and stroke [3]. The estimates for snus use come from another published meta-analysis [8]